Data is not available at this time.
Sumitomo Bakelite Company Limited operates as a key player in the specialty chemicals sector, focusing on high-performance materials for semiconductors, industrial applications, and life sciences. The company’s core revenue model is built on manufacturing and selling epoxy resins, phenolic compounds, and advanced plastic products, which are critical for semiconductor encapsulation, medical devices, and functional packaging. Its diversified portfolio serves industries such as automotive, electronics, construction, and healthcare, positioning it as a solutions provider for high-growth technological and industrial demands. With a strong emphasis on R&D, Sumitomo Bakelite maintains a competitive edge in developing innovative materials that meet stringent industry standards, particularly in semiconductor packaging and medical applications. The company’s global footprint and long-standing expertise in resin technologies reinforce its market leadership in niche segments, supported by strategic partnerships and a reputation for reliability in high-specification markets.
Sumitomo Bakelite reported revenue of JPY 287.3 billion for FY 2024, with net income of JPY 21.8 billion, reflecting a steady operational performance. The diluted EPS of JPY 233.66 indicates efficient earnings distribution. Operating cash flow stood at JPY 40.2 billion, while capital expenditures were JPY 21.9 billion, suggesting disciplined reinvestment in growth initiatives. The company’s ability to maintain profitability amid sector-specific challenges underscores its resilient business model.
The company’s earnings power is demonstrated by its consistent net income and robust operating cash flow, which supports ongoing R&D and market expansion. With a beta of 0.47, Sumitomo Bakelite exhibits lower volatility compared to the broader market, appealing to risk-averse investors. Its capital efficiency is evident in balanced capex and strong liquidity, ensuring sustainable growth without overleveraging.
Sumitomo Bakelite maintains a solid balance sheet with JPY 121.6 billion in cash and equivalents, providing ample liquidity. Total debt of JPY 48.5 billion is manageable relative to its market cap of JPY 320 billion, reflecting prudent financial management. The company’s low leverage and high cash reserves position it well to navigate economic uncertainties and fund strategic investments.
The company has shown stable growth, driven by demand for semiconductor materials and life science products. Its dividend per share of JPY 110 highlights a shareholder-friendly approach, balancing reinvestment with returns. Future growth is likely tied to advancements in semiconductor technology and expansion in healthcare markets, supported by its innovative product pipeline.
With a market cap of JPY 320 billion, Sumitomo Bakelite trades at a moderate valuation, reflecting its niche market position and steady earnings. Investors likely value its defensive qualities and exposure to high-growth sectors like semiconductors and medical devices, though broader chemical sector trends may influence performance.
Sumitomo Bakelite’s strategic advantages lie in its specialized material expertise, diversified end markets, and strong R&D focus. The outlook remains positive, supported by secular demand for advanced materials in electronics and healthcare. However, macroeconomic headwinds and raw material costs could pose challenges, requiring continued operational agility.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |